---
title: "VERAXA Biotech (NASDAQ: VRXA) Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnership"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292229412.md"
description: "VERAXA Biotech (NASDAQ: VRXA) Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnership"
datetime: "2026-07-09T17:45:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292229412.md)
  - [en](https://longbridge.com/en/news/292229412.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292229412.md)
generator: "portal-rs"
---

# VERAXA Biotech (NASDAQ: VRXA) Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnership


### Related Stocks

- [VRXA.US](https://longbridge.com/en/quote/VRXA.US.md)

## Related News & Research

- [Veraxa Biotech files Form 3 for Interim CFO Carl von Halem](https://longbridge.com/en/news/296530272.md)
- [Annita Tanini Sells 1,224 Shares of Keros Therapeutics (NASDAQ:KROS) Stock](https://longbridge.com/en/news/296537997.md)
- [Wrap Technologies (NASDAQ: WRAP) Selected to Support Florida Teacher Safety Training Program](https://longbridge.com/en/news/296129490.md)
- [Insider Selling: CommVault Systems (NASDAQ:CVLT) CAO Sells 486 Shares](https://longbridge.com/en/news/296409914.md)
- [Why Are Nebius Shares Trading Lower On Wednesday?](https://longbridge.com/en/news/296383504.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**